These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8086732)

  • 1. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus.
    Jakobsson B; Berg U
    Acta Paediatr; 1994 May; 83(5):522-5. PubMed ID: 8086732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus.
    Monnens L; Jonkman A; Thomas C
    Clin Sci (Lond); 1984 Jun; 66(6):709-15. PubMed ID: 6723207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin.
    Rascher W; Rosendahl W; Henrichs IA; Maier R; Seyberth HW
    Pediatr Nephrol; 1987 Jul; 1(3):485-90. PubMed ID: 3153321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.
    Knoers N; Monnens LA
    J Pediatr; 1990 Sep; 117(3):499-502. PubMed ID: 2391611
    [No Abstract]   [Full Text] [Related]  

  • 5. The renin-aldosterone system in nephrogenic diabetes insipidus and the influence of hydrochlorothiazide and indomethacin.
    Andersen O; Jacobsen BB
    Acta Paediatr Scand; 1983 Sep; 72(5):717-20. PubMed ID: 6637470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of micropuncture and lithium clearance methods in the assessment of renal tubular function in rats with diabetes insipidus.
    Shirley DG; Walter SJ; Thomsen K
    Pflugers Arch; 1983 Dec; 399(4):266-70. PubMed ID: 6664829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sodium depletion in hydrochlorothiazide-induced antidiuresis in Brattleboro rats with diabetes insipidus.
    Shirley DG; Walter SJ; Laycock JF
    Clin Sci Mol Med; 1978 Mar; 54(3):209-15. PubMed ID: 630797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus.
    Alon U; Chan JC
    Am J Nephrol; 1985; 5(1):9-13. PubMed ID: 3970081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative therapeutic benefit of indomethacin, hydrochlorothiazide, and acetyl-salicylic acid in a patient with nephrogenic diabetes insipidus.
    Vierhapper H; Jörg J; Favre L; Vallotton MB; Waldhäusl W
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):311-6. PubMed ID: 6588700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of indomethacin in tubular defects.
    Usberti M; Pecoraro C; Federico S; Cianciaruso B; Guida B; Romano A; Grumetto L; Carbonaro L
    Pediatrics; 1985 Mar; 75(3):501-7. PubMed ID: 3856211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A micropuncture study of proximal tubular function after acute hydrochlorothiazide administration to Brattleboro rats with diabetes insipidus.
    Walter SJ; Laycock JF; Shirley DG
    Clin Sci (Lond); 1979 Nov; 57(5):427-34. PubMed ID: 519951
    [No Abstract]   [Full Text] [Related]  

  • 12. Lithium-induced nephrogenic diabetes insipidus: studies of tubular function and pathogenesis.
    Rapoport J; Chaimovitz C; Alroy GG; Better OS
    Isr J Med Sci; 1979 Sep; 15(9):765-71. PubMed ID: 41818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
    Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
    Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: renal mechanisms.
    Shirley DG; Walter SJ; Laycock JF
    Clin Sci (Lond); 1982 Dec; 63(6):533-8. PubMed ID: 7128021
    [No Abstract]   [Full Text] [Related]  

  • 15. Proximal tubular reabsorption during hydrochlorothiazide-induced anti-diuresis in diabetes insipidus [proceedings].
    Laycock JF; Shirley DG; Walter SJ
    J Physiol; 1978 Nov; 284():74P-75P. PubMed ID: 731581
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrogenic diabetes insipidus: clinical and pathophysiological aspects.
    Niaudet P; Dechaux M; Trivin C; Loirat C; Broyer M
    Adv Nephrol Necker Hosp; 1984; 13():247-60. PubMed ID: 6089520
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus.
    Monn E
    Acta Paediatr Scand; 1981 Jan; 70(1):39-42. PubMed ID: 6782828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus: treat with caution.
    Boussemart T; Nsota J; Martin-Coignard D; Champion G
    Pediatr Nephrol; 2009 Sep; 24(9):1761-3. PubMed ID: 19373493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities of new therapeutic approaches in renal diabetes insipidus].
    Liska J; Slovácek R; Varvarovská J; Topolcan O; Karlícek V; Dvorák I
    Cesk Pediatr; 1985 Jul; 40(7):403-6. PubMed ID: 4028244
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors.
    Libber S; Harrison H; Spector D
    J Pediatr; 1986 Feb; 108(2):305-11. PubMed ID: 3080575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.